1-6 of 6
William K. Kelly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer

Open Access
Emanuela Dylgjeri, Vishal Kothari, Ayesha A. Shafi, Galina Semenova, Peter T. Gallagher, Yi F. Guan, Angel Pang, Jonathan F. Goodwin, Swati Irani, Jennifer J. McCann, Amy C. Mandigo, Saswati Chand, Christopher M. McNair, Irina Vasilevskaya, Matthew J. Schiewer, Costas D. Lallas, Peter A. McCue, Leonard G. Gomella, Erin L. Seifert, Jason S. Carroll, Lisa M. Butler, Jeff Holst, William K. Kelly, Karen E. Knudsen
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1446–1459.
https://doi.org/10.1158/1078-0432.CCR-21-1846
Published: 01 April 2022
View articletitled, A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer
Open the PDF for A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Relevance of pRB Loss in Human Malignancies

Open Access
Amy C. Mandigo, Scott A. Tomlins, William K. Kelly, Karen E. Knudsen
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (2): 255–264.
https://doi.org/10.1158/1078-0432.CCR-21-1565
Published: 19 January 2022
View articletitled, Relevance of pRB Loss in Human Malignancies
Open the PDF for Relevance of pRB Loss in Human Malignancies in another window
Journal Articles

Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer

Free
Renée de Leeuw, Lisa D. Berman-Booty, Matthew J. Schiewer, Stephen J. Ciment, Robert B. Den, Adam P. Dicker, William K. Kelly, Edouard J. Trabulsi, Costas D. Lallas, Leonard G. Gomella, Karen E. Knudsen
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4): 795–807.
https://doi.org/10.1158/1078-0432.CCR-14-1358
Published: 16 February 2015
View articletitled, Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer
Open the PDF for Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Prostate Cancer Clinical Trial End Points: “RECIST”ing a Step Backwards

Free
Howard I. Scher, Michael J. Morris, William K. Kelly, Lawrence H. Schwartz, Glenn Heller
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (14): 5223–5232.
https://doi.org/10.1158/1078-0432.CCR-05-0109
Published: 20 July 2005
View articletitled, Prostate Cancer Clinical Trial End Points: “RECIST”ing a Step Backwards
Open the PDF for Prostate Cancer Clinical Trial End Points: “RECIST”ing a Step Backwards in another window
Journal Articles

Quantifying the Amount of Variation in Survival Explained by Prostate-specific Antigen

Free
David A. Verbel, Glenn Heller, William K. Kelly, Howard I. Scher
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2576–2579.
Published: 01 August 2002
View articletitled, Quantifying the Amount of Variation in Survival Explained by Prostate-specific Antigen
Open the PDF for Quantifying the Amount of Variation in Survival Explained by Prostate-specific Antigen in another window
Journal Articles

Phase I Trial of BCL-2 Antisense Oligonucleotide (G3139) Administered by Continuous Intravenous Infusion in Patients with Advanced Cancer

Free
Michael J. Morris, William P. Tong, Carlos Cordon-Cardo, Marija Drobnjak, William K. Kelly, Susan F. Slovin, Kathryn L. Terry, Karen Siedlecki, Paul Swanson, Mohmed Rafi, Robert S. DiPaola, Neal Rosen, Howard I. Scher
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 679–683.
Published: 01 March 2002
View articletitled, Phase I Trial of BCL-2 Antisense Oligonucleotide (G3139) Administered by Continuous Intravenous Infusion in Patients with Advanced Cancer
Open the PDF for Phase I Trial of BCL-2 Antisense Oligonucleotide (G3139) Administered by Continuous Intravenous Infusion in Patients with Advanced Cancer in another window